Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 19 Aug 2026. Factsheet Jun 2026. About · Disclosures
Bajaj Finserv Healthcare Fund Direct Plan- IDCW Payout
Bajaj Finserv Mutual Fund₹12.076
As on 19 Aug 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +21.53% | — | — |
| 3 year | +12.17% | — | — |
| 5 year | +12.17% | — | — |
All Sectoral Pharma and Healthcare funds · Bajaj Finserv Mutual Fund
Returns
From NAVs through 19 Aug 2026
Calendar years
Rolling 1-year · 8 overlapping windows
Fund facts
Fund details from the Jun 2026 factsheet
Where the money is invested
Split by asset type.
By asset type
What the fund holds
39 holdings · portfolio as on 30 May 2026
- 9.07%Divi's Laboratories LtdHealthcare
- 6.73%Apollo Hospitals Enterprise LtdHealthcare
- 6.54%Sun Pharmaceuticals Industries LtdHealthcare
- 6.51%Piramal Pharma LtdHealthcare
- 6.17%Aurobindo Pharma LtdHealthcare
- 5.26%Torrent Pharmaceuticals LtdHealthcare
- 4.52%Rubicon Research LtdHealthcare
- 4.39%Neuland Laboratories LtdHealthcare
- 4.18%Emcure Pharmaceuticals LtdHealthcare
- 3.68%Max Healthcare Institute Ltd Ordinary SharesHealthcare
Concentration
Risk and quality measures
How steady the returns have been.
Return quality
Risk
Who manages this fund
3 fund managers
- SGSorbh Gupta8.7 years in the industryRuns 14 schemes
- NCNimesh Chandan6.7 years in the industryRuns 26 schemes
- SCSiddharth Chaudhary12.6 years in the industryRuns 26 schemes
Other Sectoral Pharma and Healthcare funds
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-InsureddirectCompare
HDFC Pharma and Healthcare Fund Direct Plan IDCW ReinvestmentdirectCompare
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan IDCW PayoutdirectCompare
Bandhan Healthcare FunddirectCompare
Bandhan BSE Healthcare Index Fund - Direct Plan - GrowthdirectCompare
DSP Nifty Healthcare ETF-Direct PlandirectCompare
Mirae Asset Nifty 500 Healthcare ETFdirectCompare
PGIM India Healthcare Fund Direct Plan - GrowthdirectCompare
SIP illustration
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
Other versions
- regularGrowthBajaj Finserv Healthcare Fund Regular Plan - GrowthNAV ₹9.798
- regularIDCWBajaj Finserv Healthcare Fund Regular Plan- IDCW PayoutNAV ₹9.798
- directIDCWBajaj Finserv Healthcare Fund Direct Plan- IDCW ReinvestmentNAV ₹9.956
- directGrowthBajaj Finserv Healthcare Fund Direct Plan - GrowthNAV ₹9.956
FAQ
What is Bajaj Finserv Healthcare Fund Direct Plan- IDCW Payout NAV today?
- The latest NAV of Bajaj Finserv Healthcare Fund Direct Plan- IDCW Payout is ₹12.076 as on 19 Aug 2026.
How has Bajaj Finserv Healthcare Fund Direct Plan- IDCW Payout performed vs its category?
- 1-year return +21.53%. Past performance does not guarantee future returns.
What are the returns of Bajaj Finserv Healthcare Fund Direct Plan- IDCW Payout?
- Trailing returns from published NAVs: 1 year +21.53%, 3 year +12.17% a year, 5 year +12.17% a year, since our first NAV +12.17% a year. Past performance does not guarantee future returns.
How would a SIP in Bajaj Finserv Healthcare Fund Direct Plan- IDCW Payout have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +12.17%. It is not a forecast.
What is the expense ratio and fund size of Bajaj Finserv Healthcare Fund Direct Plan- IDCW Payout?
- For Bajaj Finserv Healthcare Fund Direct Plan- IDCW Payout, the expense ratio is 0.66% and fund size (AUM) is ₹332.52 Cr.
What is the ISIN of Bajaj Finserv Healthcare Fund Direct Plan- IDCW Payout?
- The ISIN for Bajaj Finserv Healthcare Fund Direct Plan- IDCW Payout is INF0QA701AC7.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.
